首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1751660

無針設備：技術與全球市場

Needle-Free Devices: Technologies and Global Markets

出版日期: 2025年06月13日 | 出版商:

BCC Research | 英文 156 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球無針設備市場規模預計將從2024年的155億美元成長到2025年的170億美元，到2030年將達到 277億美元，2025年至2030年的年複合成長率為 10.2%。

北美市場預計將從2024年的67億美元和2025年的74億美元成長到2030年的121億美元，2025年至2030年的年複合成長率為10.4%。亞太市場預計將從2024年的25億美元和2025年的28億美元成長到2030年的50億美元，年複合成長率為12.1%。

本報告調查了全球無針設備市場，並提供了市場概況摘要、市場影響因素和市場機會分析、市場規模趨勢和預測以及各個細分市場和地區的詳細分析。

細分市場
依產品類型分類的市場
摘要
吸入器技術
經皮吸收貼片
無針注射器
其他
市場區隔：依應用
摘要
疫苗
疼痛管理
胰島素給藥
兒科藥物輸送
其他
市場區隔：依最終用戶
摘要
醫院和診所
居家照護環境
研究和學術機構
地理分佈
市場區隔：依地區
關鍵要點
北美洲
歐洲
亞太地區
南美洲
中東和非洲

第7章競爭訊息

摘要
主要企業市場佔有率
戰略分析

第8章無針設備的永續性：ESG 視角

概述
環境永續性
社會責任
管治視角
ESG風險評估
BCC的結論

第9章附錄

調查方法
來源
簡稱
公司簡介
AKRA DERMOJET
APTARGROUP INC.
ARX LLC.
ASTRAZENECA
AVAXZIPEN
CROSSJECT
ENDO INC.
GSK PLC.
HALOZYME INC.
MIKA MEDICAL CO.
NOVARTIS AG
NUGEN MEDICAL DEVICES
PHARMAJET
PRESSPART VERWALTUNGS GMBH
VIATRIS INC.
新興Start-Ups/市場顛覆者

簡介目錄圖表

Product Code: HLC178C

The global market for needle-free devices was valued at $15.5 billion in 2024 and is estimated to increase from $17.0 billion in 2025 to reach $27.7 billion by 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 through 2030.

The North American market for needle-free devices was valued at $6.7 billion in 2024 and is estimated to increase from $7.4 billion in 2025 to reach $12.1 billion by 2030, at a CAGR of 10.4% from 2025 through 2030.

The Asia-Pacific market for needle-free devices was valued at $2.5 billion in 2024 and is estimated to increase from $2.8 billion in 2025 to reach $5.0 billion by 2030, at a CAGR of 12.1% from 2025 through 2030.

Report Scope

Both qualitative and quantitative data on the current market dynamics and trends are presented in this report on the global market for needle-free devices. The report also assesses recent technological developments and product performance. Analyses of the most popular products, clinical trials, new product approvals, and emerging technologies are also included. The market prospects for five regions-North America, Europe, Asia-Pacific, South America, and the Middle East and Africa (MEA)-are discussed. The report also includes profiles of leading companies and their strategies.

The global market is segmented into the following product types: needle-free injectors, inhaler technologies, transdermal patch technologies and other novel technologies. By application, the market is segmented into vaccines, pain management, insulin delivery, pediatric injections and others. By end-user, the market is segmented into hospitals and clinics, homecare settings, and research and academic institutions. For market estimates, data has been provided for 2024 as the base year, with forecasts for 2025 through 2030.

Report Includes

49 data tables and 56 additional tables
An overview of the global market for needle-free devices and technologies
Analyses of global market trends with data from 2022 to 2025 and projected CAGRs through 2030
Highlights of the current and future market potential and quantification of the market by product type, application, end user and region
Assessment of the recent developments, key technological updates and product performance within the needle-free devices market
Insight into various needle-free technologies that are used in drug delivery and their application areas
Discussion of government regulations that can affect the global needle-free devices market
Identification of challenges and discussion on how to overcome those to reach its commercialization potential, and ESG trends of the market
Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
Company profiles of major players within the industry, including GSK plc., Novartis AG, Viatris Inc., and PharmaJet

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Overview
Macroeconomic Factors
Impact of U.S. Tariffs on the Pharmaceutical and Medical Device Industries
Population Demographics and Aging Populations
Healthcare Infrastructure and Spending
Regulatory and Policy Landscape
Technological Advances and Funding
Geopolitical Risks, Trade Wars, and Supply Chain Disruptions
Porter's Five Forces Analysis
Potential for New Entrants (Moderate to High)
Bargaining Power of Suppliers (Low to Moderate)
Bargaining Power of Buyers (Moderate to High)
Threat of Substitute Products or Services (High)
Industry Level of Competitiveness (Moderate to High)

Chapter 3 Market Dynamics

Overview
Market Drivers
Increasing Incidence of Needlestick Injuries
Preference for Painless Drug Delivery
Demand for Home Healthcare and Self-Administration
Market Restraints
Cost of Needle-Free Technology
Limitations of Large Volume and Intravenous Administration Systems
Market Opportunities
Product Innovation
Increased Investments in Healthcare in Emerging Markets

Chapter 4 Regulatory Landscape

Overview
Regulatory Scenario in the U.S.
Regulatory Scenario in Europe
Regulatory Scenario in Japan
Regulatory Scenario in China
FDA-Approved Inhalers
FDA-Approved Transdermal Patch

Chapter 5 Emerging Trends and Pipeline Analysis

Emerging Trends
Smart Patches
Smart Inhalers
Sonophoresis
3D-Printed Microarray Patches
Dissolving/Degradable Patches
Pipeline Analysis
Takeaways
Patent Analysis
Inhaler Technologies
Transdermal Patches
Needle-Free Injectors
Findings

Chapter 6 Market Segmentation Analysis

Segmentation Breakdown
Market Breakdown by Product Type
Takeaways
Inhaler Technologies
Transdermal Patches
Needle-free Injectors
Other Novel Technologies
Market Breakdown by Application
Takeaways
Vaccines
Pain Management
Insulin Delivery
Pediatric Drug Delivery
Other Applications
Market Breakdown by End-User
Takeaways
Hospital and Clinics
Homecare Settings
Research and Academic Institutions
Geographic Breakdown
Market Breakdown by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa

Chapter 7 Competitive Intelligence

Takeaways
Market Shares of Leading Companies
Strategic Analysis

Chapter 8 Sustainability in Needle-Free Devices: ESG Perspective

Overview
Environmental Sustainability
Social Responsibility
Governance Perspective
ESG Risk Ratings
Concluding Remarks from BCC Research

Chapter 9 Appendix

Research Methodology
Sources
Abbreviations
Company Profiles
AKRA DERMOJET
APTARGROUP INC.
ARX LLC.
ASTRAZENECA
AVAXZIPEN
CROSSJECT
ENDO INC.
GSK PLC.
HALOZYME INC.
MIKA MEDICAL CO.
NOVARTIS AG
NUGEN MEDICAL DEVICES
PHARMAJET
PRESSPART VERWALTUNGS GMBH
VIATRIS INC.
Emerging Start-ups/Market Disruptors

簡介目錄圖表

List of Tables

Summary Table : Global Market for Needle-Free Devices, by Region, Through 2030
Table 1 : FDA Device Classifications
Table 2 : Approved Inhalers
Table 3 : FDA-Approved Transdermal Products
Table 4 : Pipeline Drugs for Needle-Free Devices
Table 5 : Granted Patents for Inhaler Technologies, 2022-2025
Table 6 : Granted Patents for Transdermal Patches, 2022-2025
Table 7 : Granted Patents for Needle-Free Injectors, 2022-2025
Table 8 : Global Market for Needle-Free Devices, by Product Type, Through 2030
Table 9 : Global Market for Inhaler Technologies, by Type, Through 2030
Table 10 : Global Market for Inhaler Technologies, by Region, Through 2030
Table 11 : Drug Used in Transdermal Patches/Products
Table 12 : Global Market for Transdermal Patches, by Region, Through 2030
Table 13 : Comparison of the Three Medication Types of Needle-Free Injectors
Table 14 : Global Market for Needle-free Injectors, by Medication Type, Through 2030
Table 15 : Global Market for Needle-free Injectors, by Drug Delivery, Through 2030
Table 16 : Global Market for Needle-free Injectors, by Region, Through 2030
Table 17 : Global Market for Other Novel Needle-free Technologies, by Region, Through 2030
Table 18 : Global Market for Needle-Free Devices, by Application, Through 2030
Table 19 : Global Market for Needle-Free Devices, by End User, Through 2030
Table 20 : Global Market for Needle-Free Devices, by Region, Through 2030
Table 21 : North American Market for Needle-Free Devices, by Product Type, Through 2030
Table 22 : North American Market for Needle-Free Devices, by Country, Through 2030
Table 23 : U.S. Market for Needle-Free Devices, by Product Type, Through 2030
Table 24 : Canadian Market for Needle-Free Devices, by Product Type, Through 2030
Table 25 : Mexican Market for Needle-Free Devices, by Product Type, Through 2030
Table 26 : European Market for Needle-Free Devices, by Product Type, Through 2030
Table 27 : European Market for Needle-Free Devices, by Country, Through 2030
Table 28 : German Market for Needle-Free Devices, by Product Type, Through 2030
Table 29 : U.K. Market for Needle-Free Devices, by Product Type, Through 2030
Table 30 : French Market for Needle-Free Devices, by Product Type, Through 2030
Table 31 : Spanish Market for Needle-Free Devices, by Product Type, Through 2030
Table 32 : Italian Market for Needle-Free Devices, by Product Type, Through 2030
Table 33 : Rest of European Market for Needle-Free Devices, by Product Type, Through 2030
Table 34 : Asia-Pacific Market for Needle-Free Devices, by Product Type, Through 2030
Table 35 : Asia-Pacific Market for Needle-Free Devices, by Country, Through 2030
Table 36 : Chinese Market for Needle-Free Devices, by Product Type, Through 2030
Table 37 : Japanese Market for Needle-Free Devices, by Product Type, Through 2030
Table 38 : Indian Market for Needle-Free Devices, by Product Type, Through 2030
Table 39 : Rest of Asia-Pacific Market for Needle-Free Devices, by Product Type, Through 2030
Table 40 : South American Market for Needle-Free Devices, by Product Type, Through 2030
Table 41 : South American Market for Needle-Free Devices, by Country, Through 2030
Table 42 : Brazilian Market for Needle-Free Devices, by Product Type, Through 2030
Table 43 : Argentine Market for Needle-Free Devices, by Product Type, Through 2030
Table 44 : Rest of South American Market for Needle-Free Devices, by Product Type, Through 2030
Table 45 : MEA Market for Needle-Free Devices, by Product Type, Through 2030
Table 46 : MEA Market for Needle-Free Devices, by Subregion, Through 2030
Table 47 : Middle East Market for Needle-Free Devices, by Product Type, Through 2030
Table 48 : African Market for Needle-Free Devices, by Product Type, Through 2030
Table 49 : Recent Developments in the Needle-free Device Industry
Table 50 : ESG Risk Rankings for Needle-Free Device Companies, 2024*
Table 51 : Information Sources Used in this Report
Table 52 : Abbreviations Used in this Report
Table 53 : Akra Dermojet: Company Snapshot
Table 54 : Akra Dermojet: Product Portfolio
Table 55 : AptarGroup Inc.: Company Snapshot
Table 56 : AptarGroup Inc.: Financial Performance, FY 2023 and 2024
Table 57 : AptarGroup Inc.: Product Portfolio
Table 58 : AptarGroup Inc.: News/Key Developments, 2022-2024
Table 59 : ARx LLC.: Company Snapshot
Table 60 : ARx LLC: Product Portfolio
Table 61 : AstraZeneca: Company Snapshot
Table 62 : AstraZeneca: Financial Performance, FY 2023 and 2024
Table 63 : AstraZeneca: Product Portfolio
Table 64 : AstraZeneca: News/Key Developments, 2023 and 2024
Table 65 : aVaxziPen: Company Snapshot
Table 66 : aVaxziPen: Product Portfolio
Table 67 : aVaxziPen: News/Key Developments, 2024
Table 68 : CROSSJECT: Company Snapshot
Table 69 : CROSSJECT: Financial Performance, FY 2023 and 2024
Table 70 : CROSSJECT: Product Portfolio
Table 71 : CROSSJECT: News/Key Developments, 2023-2025
Table 72 : Endo Inc.: Company Snapshot
Table 73 : Endo Inc.: Financial Performance, FY 2023 and 2024
Table 74 : Endo Inc.: Product Portfolio
Table 75 : Endo Inc.: News/Key Developments, 2025
Table 76 : GSK plc.: Company Snapshot
Table 77 : GSK Plc.: Financial Performance, FY 2023 and 2024
Table 78 : GSK Plc.: Product Portfolio
Table 79 : GSK Plc.: News/Key Developments, 2025
Table 80 : Halozyme Inc.: Company Snapshot
Table 81 : Halozyme Inc.: Financial Performance, FY 2023 and 2024
Table 82 : Halozyme Inc.: Product Portfolio
Table 83 : Halozyme Inc.: News/Key Developments, 2023-2025
Table 84 : MIKA MEDICAL CO.: Company Snapshot
Table 85 : MIKA MEDICAL CO: Product Portfolio
Table 86 : Novartis AG: Company Snapshot
Table 87 : Novartis AG: Financial Performance, FY 2023 and 2024
Table 88 : Novartis AG: Product Portfolio
Table 89 : Novartis AG: News/Key Developments, 2020
Table 90 : NuGen Medical Devices: Company Snapshot
Table 91 : NuGen Medical Devices: Financial Performance, FY 2023 and 2024
Table 92 : NuGen Medical Devices: Product Portfolio
Table 93 : NuGen Medical Devices: News/Key Developments, 2023-2025
Table 94 : PharmaJet: Company Snapshot
Table 95 : PharmaJet: Product Portfolio
Table 96 : PharmaJet: News/Key Developments, 2023-2024
Table 97 : Presspart Verwaltungs GmbH: Company Snapshot
Table 98 : Presspart Verwaltungs GmbH: Product Portfolio
Table 99 : Presspart Verwaltungs GmbH.: News/Key Developments, 2023 and 2024
Table 100 : Viatris Inc.: Company Snapshot
Table 101 : Viatris Inc.: Financial Performance, FY 2023 and 2024
Table 102 : Viatris Inc.: Product Portfolio
Table 103 : Viatris Inc.: News/Key Developments, 2022
Table 104 : Emerging Startups

List of Figures

Summary Figure : Global Market Shares of Needle-Free Devices, by Region, 2024
Figure 1 : Porter's Five Forces Analysis
Figure 2 : Market Dynamics of Needle-Free Devices
Figure 3 : Needlestick Injuries in Hospitals, by Department
Figure 4 : Patents for Inhaler Technologies, 2022-2025
Figure 5 : Patents for Transdermal Patches, 2022-2025
Figure 6 : Patents for Needle-Free Injectors, 2022-2025
Figure 7 : Global Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 8 : Global Market Shares of Inhaler Technologies, by Region, 2024
Figure 9 : Global Market Shares of Transdermal Patches, by Region, 2024
Figure 10 : Global Market Shares of Needle-free Injectors, by Region, 2024
Figure 11 : Global Market Shares of Other Novel Needle-free Technologies, by Region, 2024
Figure 12 : Global Market Shares of Needle-Free Devices, by Application, 2024
Figure 13 : Global Market Shares of Needle-Free Devices, by End User, 2024
Figure 14 : Global Market Shares of Needle-Free Devices, by Region, 2024
Figure 15 : North American Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 16 : North American Market Shares of Needle-Free Devices, by Country, 2024
Figure 17 : U.S. Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 18 : Canadian Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 19 : Mexican Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 20 : European Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 21 : European Market Shares of Needle-Free Devices, by Country, 2024
Figure 22 : German Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 23 : U.K. Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 24 : French Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 25 : Spanish Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 26 : Italian Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 27 : Rest of European Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 28 : Asia-Pacific Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 29 : Asia-Pacific Market Shares of Needle-Free Devices, by Country, 2024
Figure 30 : Chinese Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 31 : Japanese Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 32 : Indian Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 33 : Rest of Asia-Pacific Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 34 : South American Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 35 : South American Market Shares of Needle-Free Devices, by Country, 2024
Figure 36 : Brazilian Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 37 : Argentine Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 38 : Rest of South American Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 39 : MEA Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 40 : MEA Market Shares of Needle-Free Devices, by Subregion, 2024
Figure 41 : Middle East Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 42 : African Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 43 : Needle-Free Device Makers Global Market Shares, 2024
Figure 44 : AptarGroup Inc.: Revenue Share, by Business Unit, FY 2024
Figure 45 : AptarGroup Inc.: Revenue Share, by Region/Country, FY 2024
Figure 46 : ASTRAZENECA: Revenue Share, by Business Unit, FY 2024
Figure 47 : ASTRAZENECA: Revenue Share, by Region/Country, FY 2024
Figure 48 : Endo Inc.: Revenue Share, by Business Unit, FY 2024
Figure 49 : GSK Plc.: Revenue Share, by Business Unit, FY 2024
Figure 50 : GSK Plc.: Revenue Share, by Country/Region, FY 2024
Figure 51 : Halozyme Inc.: Revenue Share, by Business Unit, FY 2024
Figure 52 : Halozyme Inc.: Revenue Share, by Country/Region, FY 2024
Figure 53 : Novartis AG: Revenue Share, by Business Unit, FY 2024
Figure 54 : Novartis AG: Revenue Share, by Country/Region, FY 2024
Figure 55 : Viatris Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 56 : Viatris Inc.: Revenue Shares, by Country/Region, FY 2024